CoChat
Cited by 196

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Platelet Derivatives in Regenerative Medicine: An Update

De Pascale, Maria Rosaria, Sommese, Linda, Casamassimi, Amelia, Napoli, Claudio · 2015 · Transfusion Medicine Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tmrv.2014.11.001

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 132

  1. Velnar, 2009, The wound healing process: an overview of the cellular and molecular mechanisms, J Int Med Res, 37, 1528, 10.1177/147323000903700531 · DOI · Paper page
  2. Suzuki, 2013, Gelatin gel as a carrier of platelet-derived growth factors, J Biomater Appl, 28, 595, 10.1177/0885328212468183 · doi:10.1177/0885328212468183
  3. Eppley, 2006, Platelet-rich plasma: a review of biology and applications in plastic surgery, Plast Reconstr Surg, 118, 147, 10.1097/01.prs.0000239606.92676.cf · DOI · Paper page
  4. Nurden, 2008, Platelets and wound healing, Front Biosci, 13, 3532
  5. Serra, 2013, Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients, Int Wound J, 10, 612, 10.1111/iwj.12052 · doi:10.1111/iwj.12052
  6. Anitua, 2013, Release kinetics of platelet-derived and plasma derived growth Factors from autologous plasma rich in growth factors, Ann Anat, 195, 461, 10.1016/j.aanat.2013.04.004 · DOI
  7. Doucet, 2005, Platelet lisates promote mesenchimal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications, J Cell Physiol, 205, 228, 10.1002/jcp.20391 · DOI · Paper page
  8. Salvadè, 2010, Characterization of platelet lysate cultured mesenchimal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects, Tissue Eng Part C Methods, 16, 201, 10.1089/ten.tec.2008.0572 · DOI
  9. Gentile, 2012, A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet rich plasma improves fat grafting maintenance in breast reconstruction, Stem Cell Transl Med, 1, 341, 10.5966/sctm.2011-0065 · DOI · Paper page
  10. You, 2013, Effects of human epidermal growth factor gene-transfected mesenchymal stem cells on fibroblast migration and proliferation, Cell Prolif, 46, 408, 10.1111/cpr.12042 · DOI
  11. Hubbard, 2000, Protein tyrosine kinase structure and function, Annu Rev Biochem, 69, 373, 10.1146/annurev.biochem.69.1.373 · DOI · Paper page
  12. Montmayeur, 1997, The platelet-derived growth factor beta receptor triggers multiple cytoplasmic signaling cascades that arrive at the nucleus as distinguishable inputs, J Biol Chem, 272, 32670, 10.1074/jbc.272.51.32670 · DOI
  13. Wrana, 2000, Regulation of Smad activity, Cell, 100, 189, 10.1016/S0092-8674(00)81556-1 · DOI · Paper page
  14. Andrae, 2008, Role of platelet-derived growth factors in physiology and medicine, Genes Dev, 22, 1276, 10.1101/gad.1653708 · DOI · Paper page
  15. Graham, 2009, Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing, Expert Opin Investig Drugs, 18, 1633, 10.1517/13543780903241607 · DOI
  16. Ghosh, 2014, Integral role of platelet derived growth factor in mediating transforming growth factor-β1 dependent mesenchymal stem cell stiffening, Stem Cells Dev, 23, 245, 10.1089/scd.2013.0240 · DOI
  17. Sonmez, 2014, Applications of basic fibroblastic growth factor (FGF-2, bFGF) in dentistry, Dent Traumatol, 30, 107, 10.1111/edt.12071 · doi:10.1111/edt.12071
  18. Ito, 2011, Wound-induced TGF-β1 and TGF-β2 enhance airway epithelial repair via HB-EGF and TGF-α, Biochem Biophys Res Commun, 412, 109, 10.1016/j.bbrc.2011.07.054 · DOI
  19. McNary, 2014, Transforming growth factor β-induced superficial zone protein accumulation in the surface zone of articular cartilage is dependent on the cytoskeleton, Tissue Eng Part A, 20, 921, 10.1089/ten.tea.2013.0043 · DOI
  20. El-Sharkawy, 2007, Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties, J Periodontol, 78, 661, 10.1902/jop.2007.060302 · DOI · Paper page
  21. Bao, 2009, The role of vascular endothelial growth factor in wound healing, J Surg Res, 153, 347, 10.1016/j.jss.2008.04.023 · DOI · Paper page
  22. Kubota, 2004, Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets, J Biochem, 136, 279, 10.1093/jb/mvh126 · DOI
  23. Brown, 1988, Acceleration of tensile strength of incisions treated with EGF and TGF-β, Ann Surg, 208, 788, 10.1097/00000658-198812000-00019 · DOI · Paper page
  24. Akingboye, 2010, Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer, J Extra Corpor Technol, 42, 20, 10.1051/ject/201042020 · DOI
  25. Villela, 2010, Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review, Growth Factors, 28, 111, 10.3109/08977190903468185 · DOI
  26. Steed, 2006, Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers, Plast Reconstr Surg, 117, 143S, 10.1097/01.prs.0000222526.21512.4c · DOI · Paper page
  27. Marques, 2014, Platelet-rich plasma (PRP): methodological aspects and clinical applications, Platelets, 10.3109/09537104.2014.881991 · DOI · Paper page
  28. Dallari, 2007, Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells, J Bone Joint Surg Am, 89, 2413, 10.2106/JBJS.F.01026 · DOI · Paper page
  29. Pallotta, 2014, Characteristics of platelet gels combined with silk, Biomaterials, 35, 3678, 10.1016/j.biomaterials.2013.12.065 · DOI
  30. Dauendorffer, 2013, Basal cell carcinoma following platelet-rich plasma injection for skin rejuvenation, Ann Dermatol Venereol, 140, 723, 10.1016/j.annder.2013.07.010 · doi:10.1016/j.annder.2013.07.010
  31. Allain, 2005, Protecting the blood supply from emerging pathogens: the role of pathogen inactivation, Transfus Med Rev, 19, 110, 10.1016/j.tmrv.2004.11.005 · DOI
  32. Burnouf, 2000, Reducing the risk of infection from plasma products: specific preventative strategies, Blood Rev, 14, 94, 10.1054/blre.2000.0129 · DOI · Paper page
  33. Thanathanee, 2013, Contamination risk of 100% autologous serum eye drops in management of ocular surface diseases, Cornea, 32, 1116, 10.1097/ICO.0b013e3182910036 · doi:10.1097/ico.0b013e3182910036
  34. Greppi, 2011, Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients, Biologicals, 39, 73, 10.1016/j.biologicals.2011.01.002 · doi:10.1016/j.biologicals.2011.01.002
  35. Mazzucco, 2008, Platelet rich plasma and platelet gel preparation using platelet, Vox Sang, 94, 202, 10.1111/j.1423-0410.2007.01027.x · doi:10.1111/j.1423-0410.2007.01027.x
  36. Mazzucco, 2009, Not every PRP-gel is born equal. Evaluation of growth factor avaibility for tissues trought four PRP-gel preparations: Fibrinet, Regen PRP-kit, Platelex and one manual procedure, Vox Sang, 97, 110, 10.1111/j.1423-0410.2009.01188.x · DOI · Paper page
  37. Amable, 2013, Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors, Stem Cell Res Ther, 4, 67, 10.1186/scrt218 · DOI · Paper page
  38. Staudenmaier, 2009, Optimization of platelet isolation and extraction of autogenous TGF-beta in cartilage tissue engineering, Artif Cells Blood Substit Immobil Biotechnol, 37, 265, 10.3109/10731190903356446 · doi:10.3109/10731190903356446
  39. Everts, 2006, Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation, Transfus Med, 16, 363, 10.1111/j.1365-3148.2006.00708.x · DOI
  40. Anitua, 2009, Fibroblastic response to treatment with different preparations rich in growth factors, Cell Prolif, 42, 162, 10.1111/j.1365-2184.2009.00583.x · DOI · Paper page
  41. Dohan Ehrenfest, 2014, Classification of platelet concentrates (platelet-rich plasma—PRP, platelet-rich fibrin—PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives, Muscles Ligaments Tendons J, 4, 3, 10.32098/mltj.01.2014.02 · DOI · Paper page
  42. Jo, 2013, Optimizing platelet-rich plasma gel formation by varying time and gravitational forces during centrifugation, J Oral Implantol, 39, 525, 10.1563/AAID-JOI-D-10-00155 · DOI
  43. Graziani, 2006, The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts, Clin Oral Implants Res, 17, 212, 10.1111/j.1600-0501.2005.01203.x · DOI · Paper page
  44. Rappl, 2011, Effect of platelet rich plasma gel in a physiologically relevant platelet concentration on wounds in persons with spinal cord injury, Int Wound J, 8, 187, 10.1111/j.1742-481X.2011.00770.x · doi:10.1111/j.1742-481x.2011.00770.x
  45. Giusti, 2014, Platelet concentration in platelet-rich plasma affects tenocyte behavior in vitro, Biomed Res Int, 2014, 630870, 10.1155/2014/630870 · DOI
  46. Lacoste, 2003, Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release, J Periodontol, 74, 1498, 10.1902/jop.2003.74.10.1498 · doi:10.1902/jop.2003.74.10.1498
  47. Su, 2004, Platelet-derived growth factor-AB and transforming growth factor-beta 1 in platelet gels activated by single-donor human thrombin, Transfusion, 44, 945, 10.1111/j.1537-2995.2004.00382.x · doi:10.1111/j.1537-2995.2004.00382.x
  48. Rodgers, 2011, Immune-mediated coagulophaty associated with topical bovine thrombin: a review of the pediatric literature, J Pediatr Hematol Oncol, 33, 86, 10.1097/MPH.0b013e3181ff0e43 · doi:10.1097/mph.0b013e3181ff0e43
  49. Clark, 2008, Topical bovine thrombin and adverse events: a review of the literature, Curr Med Res Opin, 24, 2071, 10.1185/03007990802186417 · doi:10.1185/03007990802186417
  50. Su, 2008, Assessment of the kinetics of growth factors release from platelet gel, Transfusion, 48, 2414, 10.1111/j.1537-2995.2008.01862.x · DOI
  51. Weibrich, 2002, Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count, J Craniomaxillofac Surg, 30, 97, 10.1054/jcms.2002.0285 · DOI · Paper page
  52. Galiano, 2004, Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow–derived cells, Am J Pathol, 164, 1935, 10.1016/S0002-9440(10)63754-6 · DOI · Paper page
  53. Choukroun, 2006, Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, 56, 10.1016/j.tripleo.2005.07.011 · DOI
  54. Dohan Ehrenfest, 2009, Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF), Trends Biotechnol, 27, 158, 10.1016/j.tibtech.2008.11.009 · DOI · Paper page
  55. Passaretti, 2014, Growth-promoting action and growth factor release by different platelet derivatives, Platelets, 25, 252, 10.3109/09537104.2013.809060 · DOI
  56. Geremicca, 2010, Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms, Blood Transfus, 8, 107
  57. Geerling, 2004, Autologous serum eye drops for ocular surface disorders, Br J Ophthalmol, 88, 1467, 10.1136/bjo.2004.044347 · doi:10.1136/bjo.2004.044347
  58. López-García, 2008, Autologous serum eyedrops in the treatment of aniridic keratopathy, Ophthalmology, 115, 262, 10.1016/j.ophtha.2007.03.087 · DOI
  59. Cho, 2013, Comparison of autologous serum eye drops with different diluents, Curr Eye Res, 38, 9, 10.3109/02713683.2012.720340 · doi:10.3109/02713683.2012.720340
  60. Yamada, 2008, Autologous serum eyedrops: literature review and implications for transfusion medicine specialists, Transfusion, 48, 1245, 10.1111/j.1537-2995.2008.01665.x · doi:10.1111/j.1537-2995.2008.01665.x
  61. Quinto, 2008, Autologous serum for ocular surface diseases, Arq Bras Oftalmol, 71, 47, 10.1590/S0004-27492008000700010 · doi:10.1590/s0004-27492008000700010
  62. Marx, 1998, Platelet-rich plasma: growth factor enhancement for bone grafts, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85, 638, 10.1016/S1079-2104(98)90029-4 · DOI · Paper page
  63. Burnouf, 2013, Blood-derived biomaterials and platelet growth factors in regenerative medicine, Blood Rev, 27, 77, 10.1016/j.blre.2013.02.001 · DOI · Paper page
  64. Carter, 2011, Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis, Eplasty, 11, e38
  65. Martínez-Zapata, 2009, Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review, Transfusion, 49, 44, 10.1111/j.1537-2995.2008.01945.x · DOI
  66. Tang, 2002, Antimicrobial peptides from human platelets, Infect Immun, 70, 6524, 10.1128/IAI.70.12.6524-6533.2002 · DOI · Paper page
  67. Li, 2013, PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP, J Vis Exp, 74
  68. Chen, 2013, Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro, J Diabetes Res, 2013, 269527, 10.1155/2013/269527 · doi:10.1155/2013/269527
  69. Różalski, 2013, Antimicrobial/anti-biofilm activity of expired blood platelets and their released products, Postepy Hig Med Dosw, 22, 321, 10.5604/17322693.1046009 · doi:10.5604/17322693.1046009
  70. Burnouf, 2013, Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria, Transfusion, 53, 138, 10.1111/j.1537-2995.2012.03668.x · DOI
  71. Edelblute, 2014, Human platelet gel supernatant inactivates opportunistic wound pathogens on skin, Platelets
  72. Cieslik-Bielecka, 2012, Microbicidal properties of leukocyte- and platelet-rich plasma/fibrin (L-PRP/L-PRF): new perspectives, J Biol Regul Homeost Agents, 26, 43S
  73. Martinez-Zapata, 2012, Autologous platelet-rich plasma for treating chronic wounds, Cochrane Database Syst Rev, 10, CD006899
  74. Zavadil, 2007, Autologous platelet gel and platelet poor plasma reduce pain with total shoulder arthroplasty, J Extra Corpor Technol, 39, 177, 10.1051/ject/200739177 · DOI
  75. Aggarwal, 2014, Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study, Int Orthop, 38, 387, 10.1007/s00264-013-2136-6 · DOI
  76. Valhondo, 2013, New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo, J Med Chem, 56, 7851, 10.1021/jm400766k · DOI
  77. Hackel, 2013, The connection of monocytes and reactive oxygen species in pain, PLoS One, 8, e63564, 10.1371/journal.pone.0063564 · DOI
  78. Sanchez, 2012, Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip, Rheumatology, 51, 144, 10.1093/rheumatology/ker303 · doi:10.1093/rheumatology/ker303
  79. Mei-Dan, 2012, Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus, Am J Sports Med, 40, 534, 10.1177/0363546511431238 · DOI · Paper page
  80. Andia, 2011, Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice?, Expert Opin Biol Ther, 11, 509, 10.1517/14712598.2011.554813 · doi:10.1517/14712598.2011.554813
  81. Kuffler, 2013, Platelet-rich plasma and the elimination of neuropathic pain, Mol Neurobiol, 48, 315, 10.1007/s12035-013-8494-7 · DOI
  82. Hechtman, 2011, Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis, Orthopedics, 34, 92, 10.3928/01477447-20101221-05 · DOI
  83. de Vos, 2014, Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review, Br J Sports Med, 48, 952, 10.1136/bjsports-2013-093281 · DOI · Paper page
  84. de Vos, 2010, Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial, JAMA, 303, 144, 10.1001/jama.2009.1986 · DOI · Paper page
  85. Sampson, 2008, Platelet rich plasma injection grafts for muscoloskeletal injures: a review, Curr Rev Musculoskelet Med, 1, 165, 10.1007/s12178-008-9032-5 · DOI · Paper page
  86. Shan, 2013, Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes, Int J Low Extrem Wounds, 12, 22, 10.1177/1534734613477113 · DOI
  87. Scevola, 2010, Allogenic platelet gel in the treatment of pressure sores: a pilot study, Int Wound J, 7, 184, 10.1111/j.1742-481X.2010.00671.x · doi:10.1111/j.1742-481x.2010.00671.x
  88. Giuggioli, 2012, Platelet gel in the treatment of severe scleroderma skin ulcers, Rheumatol Int, 32, 2929, 10.1007/s00296-011-2038-0 · doi:10.1007/s00296-011-2038-0
  89. Del Fabbro, 2009, Immediate implant placament into fresh extraction sites with chronic periapical pathologic features combined with plasma rich in growth factors: preliminary results of single-cohort study, J Oral Maxillofac Surg, 67, 2476, 10.1016/j.joms.2009.04.063 · doi:10.1016/j.joms.2009.04.063
  90. Forni, 2013, Platelet gel: applications in dental regenerative surgery, Blood Transfus, 11, 102
  91. Cervellin, 2012, Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study, Knee Surg Sports Traumatol Arthrosc, 20, 114, 10.1007/s00167-011-1570-5 · DOI · Paper page
  92. Virchenko, 2006, Indipendent and additive stimulation of tendon repair by thrombin and platelets, Acta Orthop, 77, 960, 10.1080/17453670610013295 · DOI
  93. Vogrin, 2010, Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial, Eur Surg Res, 45, 77, 10.1159/000318597 · DOI
  94. Gardner, 2007, The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion, Int Orthop, 31, 309, 10.1007/s00264-006-0174-z · DOI
  95. Crawford, 2007, Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis, QJM, 100, 65, 10.1093/qjmed/hcl140 · DOI · Paper page
  96. Shin, 2014, The effects of platelet-rich clot releasate on the expression of MMP-1 and type I collagen in human adult dermal fibroblasts: PRP is a stronger MMP-1 stimulator, Mol Biol Rep, 41, 3, 10.1007/s11033-013-2718-9 · DOI
  97. Kushida, 2013, Effects of platelet-rich plasma on proliferation and myofibroblastic differentiation in human dermal fibroblasts, Ann Plast Surg, 71, 219, 10.1097/SAP.0b013e31823cd7a4 · DOI
  98. Gentzkow, 1996, Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers, Diabetes Care, 19, 350, 10.2337/diacare.19.4.350 · DOI · Paper page
  99. Crovetti, 2004, Platelet gel for healing cutaneous chronic wounds, Transfus Apher Sci, 30, 145, 10.1016/j.transci.2004.01.004 · DOI · Paper page
  100. Driver, 2006, Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers, Ostomy Wound Manage, 52, 68
  101. Mahmoud, 2008, Split-skin graft in the management of diabetic foot ulcers, J Wound Care, 17, 303, 10.12968/jowc.2008.17.7.30522 · DOI
  102. Zhao, 2003, Consequences of knocking out BMP signaling in the mouse, Genesis, 35, 43, 10.1002/gene.10167 · DOI · Paper page
  103. Maeda, 2013, Prospective potency of TGF-β1 on maintenance and regeneration of periodontal tissue, Int Rev Cell Mol Biol, 304, 283, 10.1016/B978-0-12-407696-9.00006-3 · DOI
  104. Alsousou, 2009, The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature, J Bone Joint Surg (Br), 91, 987, 10.1302/0301-620X.91B8.22546 · DOI · Paper page
  105. Napolitano, 2012, Autologous platelet gel for tissue regeneration in degenerative disorders of the knee, Blood Transfus, 10, 72
  106. Wasterlain, 2013, The systemic effects of platelet-rich plasma injection, Am J Sports Med, 41, 186, 10.1177/0363546512466383 · DOI · Paper page
  107. Anitua, 2011, Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1–induced myodifferentiation, Invest Ophthalmol Vis Sci, 52, 6066, 10.1167/iovs.11-7302 · doi:10.1167/iovs.11-7302
  108. Kojima, 2008, Autologous serum eye drops for the treatment of dry eyes disease, Cornea, 27, 25, 10.1097/ICO.0b013e31817f3a0e · doi:10.1097/ico.0b013e31817f3a0e
  109. Dalmon, 2012, Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit, Arch Ophthalmol, 130, 1612, 10.1001/archophthalmol.2012.1652 · doi:10.1001/archophthalmol.2012.1652
  110. Na, 2012, Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease, J Ocul Pharmacol Ther, 28, 479, 10.1089/jop.2012.0002 · doi:10.1089/jop.2012.0002
  111. Freire, 2012, In vitro effects of three blood derivatives on human corneal epithelial cells, Invest Ophthalmol Vis Sci, 53, 5571, 10.1167/iovs.11-7340 · doi:10.1167/iovs.11-7340
  112. Jeng, 2009, Autologous serum 50% eyedrops in the treatment of persistent epithelial defects, Cornea, 28, 1104, 10.1097/ICO.0b013e3181a2a7f6 · doi:10.1097/ico.0b013e3181a2a7f6
  113. Fini, 2005, How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes, Cornea, 24, S2, 10.1097/01.ico.0000178743.06340.2c · DOI · Paper page
  114. Saika, 2006, TGFbeta pathobiology in the eye, Lab Invest, 86, 106, 10.1038/labinvest.3700375 · DOI · Paper page
  115. Maltseva, 2001, Fibroblast growth factor reversal of the corneal myofibroblast phenotype, Invest Ophthalmol Vis Sci, 42, 2490
  116. Sakimoto, 2006, Laser eye surgery for refractive errors, Lancet, 29, 1432, 10.1016/S0140-6736(06)68275-5 · doi:10.1016/s0140-6736(06)68275-5
  117. Kesavan, 2011, Newer approaches for optimal bioavailability of ocularly delivered drugs: review, Curr Drug Deliv, 8, 172, 10.2174/156720111794479925 · doi:10.2174/156720111794479925
  118. Urzua, 2012, Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome, Curr Eye Res, 37, 684, 10.3109/02713683.2012.674609 · doi:10.3109/02713683.2012.674609
  119. Pan, 2013, Autologous serum eye drops for dry eye, Cochrane Database Syst Rev, 8, CD009327
  120. Bertrand-Duchesne, 2010, Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro, J Periodontal Res, 45, 87, 10.1111/j.1600-0765.2009.01205.x · DOI
  121. Cicha, 2004, Activated human platelets release connective tissue growth factor, Thromb Haemost, 91, 755, 10.1160/TH03-09-0602 · DOI
  122. Kaul, 2012, Autologous platelet rich plasma after third molar surgery: a comparative study, J Maxillofac Oral Surg, 11, 200, 10.1007/s12663-011-0311-0 · doi:10.1007/s12663-011-0311-0
  123. Girish Rao, 2013, Bone regeneration in extraction sockets with autologous platelet rich fibrin gel, J Maxillofac Oral Surg, 12, 11, 10.1007/s12663-012-0370-x · DOI
  124. Jo, 2011, Does platelet-rich plasma accelerate recovery after rotator cuff repair? A prospective cohort study, Am J Sports Med, 39, 2082, 10.1177/0363546511413454 · DOI · Paper page
  125. Bernuzzi, 2014, Use of platelet-rich plasma in the care of sports injuries: our experience with ultrasound-guided injection, Blood Transfus, 12, 229
  126. Peerbooms, 2010, Use of platelet rich plasma to treat plantar fasciitis: design of a multi centre randomized controlled trial, BMC Musculoskelet Disord, 11, 69, 10.1186/1471-2474-11-69 · DOI
  127. Tzeng, 2013, Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series, Biomed Res Int, 2013, 837620, 10.1155/2013/837620 · doi:10.1155/2013/837620
  128. Chignon-Sicard, 2012, Efficacy of leukocyte- and platelet-rich fibrin in wound healing: a randomized controlled clinical trial, Plast Reconstr Surg, 130, 819e, 10.1097/PRS.0b013e31826d1711 · doi:10.1097/prs.0b013e31826d1711
  129. Sclafani, 2012, Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix, Arch Facial Plast Surg, 14, 132, 10.1001/archfacial.2011.784 · doi:10.1001/archfacial.2011.784
  130. Chen, 2010, The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty, Am J Ophthalmol, 150, 352, 10.1016/j.ajo.2010.03.024 · doi:10.1016/j.ajo.2010.03.024
  131. Liu, 2006, Corneal epitheliotrophic capacity of three different blood-derived preparations, Invest Ophthalmol Vis Sci, 47, 2438, 10.1167/iovs.05-0876 · DOI
  132. Lekhanont, 2013, Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery, Biomed Res Int, 2013, 521315, 10.1155/2013/521315 · doi:10.1155/2013/521315

Cited by

See all 196

Metadata

Authors
De Pascale, M. R., Sommese, L., Casamassimi, A., & Napoli, C.
Venue
Transfusion Medicine Reviews
Publisher
Elsevier BV
Published
2015-01
Volume
29
Issue
1
Pages
52-61
ISSN
0887-7963 (ISSN-L)
OpenAlex
W1996439579
Cited by
196
References
3
FWCI
13.91
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.